Smoking-induced monocyte dysfunction is reversed by vitamin C supplementation in vivo

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Nadina Stadler - , Maastricht University (Author)
  • Juliane Eggermann - (Author)
  • Stefan Vöö - (Author)
  • Andrea Kranz - , Chair of Applied Genomics (Author)
  • Johannes Waltenberger - (Author)

Abstract

OBJECTIVE: The role of antioxidants in preventing vascular disease remains controversial. Vascular endothelial growth factor (VEGF-A) is important for endothelial and monocyte function. This study investigated the negative effects of smoking on monocyte migratory responsiveness to VEGF-A and the usefulness of vitamin C to prevent smoking-induced monocyte dysfunction.

METHODS AND RESULTS: The chemotactic response of isolated monocytes from a cohort of 17 non-smokers and 10 smokers toward VEGF-A was assessed. VEGF-A significantly stimulated the migration of monocytes in non-smokers; the monocytes from smokers failed to respond to VEGF-A. Repeated analysis after 2 weeks of vitamin C intake (2 g/d) showed a fully restored VEGF-A-induced monocyte migration in smokers. VEGF-A serum levels were not altered by vitamin C. VEGF-A-inducible kinase activity was intact in monocytes from smokers as assessed by in vitro kinase assay. Monocyte dysfunction can be mimicked in vitro by challenging monocytes with a range of reactive oxygen species (ROS).

CONCLUSIONS: Stimulation of monocyte migration by VEGF-A was severely attenuated in smokers, and the deficit observed was surmounted by vitamin C supplementation. The negative effects of smoking on monocyte function may translate into adverse impacts on VEGF-A-dependent repair processes such as arteriogenesis. These results propose a causative role of oxidative stress in smoking-induced monocyte dysfunction.

Details

Original languageEnglish
Pages (from-to)120-6
Number of pages7
JournalArteriosclerosis, thrombosis, and vascular biology
Volume27
Issue number1
Publication statusPublished - Jan 2007
Peer-reviewedYes

External IDs

Scopus 33847651710
ORCID /0000-0002-7481-0220/work/142247422

Keywords

Sustainable Development Goals

Keywords

  • Adult, Antioxidants/pharmacology, Ascorbic Acid/pharmacology, Cardiovascular Diseases/etiology, Cell Movement/drug effects, Chemotaxis/drug effects, Dietary Supplements, Humans, Male, Monocytes/drug effects, Oxidative Stress/physiology, Reactive Oxygen Species/pharmacology, Risk Factors, Smoking/adverse effects, Vascular Endothelial Growth Factor A/pharmacology